All In Biotech

Free tool

FAERS Monitor: Pepcid Ac

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020801 or its brand name (Pepcid Ac, Famotidine). Reports on generic versions are filed under their own applications.

Reports

84,069

Serious

56,178

67% of reports

Hospitalization

28,086

Death reported

8,060

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • nausea5,466
  • fatigue5,213
  • diarrhoea5,066
  • chronic kidney disease4,686
  • off label use4,350
  • drug ineffective4,121
  • dyspnoea4,001
  • headache3,740
  • acute kidney injury3,418
  • vomiting3,314
  • pain3,253
  • dizziness3,130
  • death2,854
  • pneumonia2,733
  • pyrexia2,666

Reports by year received

View as table
YearReports
2004743
2005736
2006692
2007679
2008850
2009721
20101,023
20111,563
20121,933
20131,154
20141,431
20152,430
20162,920
20173,227
20184,565
20195,504
20206,624
20216,789
20227,276
20237,328
20248,572
20259,562
20267,743

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,970,090 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
chronic kidney diseaseSignal4,68616.415.963,705
acute kidney injurySignal3,4185.75.513,017
pneumoniaSignal2,7332.12.01,630
diarrhoea5,0662.01.92,480
pyrexia2,6661.91.91,214
dyspnoea4,0011.81.71,377
vomiting3,3141.81.71,124
nausea5,4661.71.71,748
fatigue5,2131.71.61,478
dizziness3,1301.61.5666
headache3,7401.51.4628
pain3,2531.31.3268
off label use4,3501.21.2216
death2,8540.80.8105
drug ineffective4,1210.80.8267

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.